TREA

97668847 - TRIUMPH

Follow

Information

  • Trademark
  • 97668847
  • Serial Number
    97668847
  • Filing Date
    November 08, 2022
    a year ago
  • Transaction Date
    February 13, 2024
    4 months ago
  • Status Date
    February 13, 2024
    4 months ago
  • Published for Opposition Date
    December 19, 2023
    6 months ago
  • Location Date
    February 13, 2024
    4 months ago
  • Status Code
    688
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    MCMORROW, JANICE LEE
  • Attorney Name
    Nancy Sabarra
    Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
TRIUMPH
Case File Statements
  • GS0051: Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, medical, biological and pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viral diseases and respiratory disorders; mRNA-based therapeutics in the nature of therapeutic agents and therapeutic agents for use in vivo, ex vivo, or in situ for the prevention and treatment of viruses and respiratory disorders; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations for intracellular delivery of self-amplifying messenger RNA (sa-mRNA) for preventing and treating viral diseases all for pharmaceutical, medical or medical diagnostic purposes; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations; pharmaceutical preparations, namely, messenger RNA (mRNA) therapeutic agents and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells
  • GS0011: Active biological ingredients for use in the manufacture of pharmaceuticals, namely, self-amplifying messenger RNA (sa-mRNA) encapsulated in a lipid nanoparticle composed of a cationic lipid and three helper lipids for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research; biochemicals for medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use
  • GS0441: Medical services; medical information; providing a website featuring medical information
  • GS0421: Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
Case File Event Statements
  • 2/13/2024 - 4 months ago
    19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/19/2023 - 6 months ago
    18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/19/2023 - 6 months ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/29/2023 - 7 months ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/15/2023 - 7 months ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/14/2023 - 7 months ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/13/2023 - 7 months ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/13/2023 - 7 months ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/16/2023 - 10 months ago
    11 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 8/16/2023 - 10 months ago
    10 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 5/22/2023 - a year ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/22/2023 - a year ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/22/2023 - a year ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/15/2023 - a year ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/21/2023 - a year ago
    5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 2/21/2023 - a year ago
    4 - ASSIGNED TO LIE Type: ALIE
  • 12/15/2022 - a year ago
    3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 11/29/2022 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/11/2022 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP